bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -28.71M | -60.81M | -81.39M | -69.80M | -80.82M |
Total Depreciation and Amortization | 13.91M | 15.34M | 16.53M | 15.47M | 8.87M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 11.96M | 12.59M | 15.82M | 9.13M | 20.55M |
Change in Net Operating Assets | -47.32M | -36.06M | -17.20M | -29.47M | -2.73M |
Cash from Operations | -50.16M | -68.93M | -66.25M | -74.68M | -54.14M |
Capital Expenditure | -485.00K | -280.00K | -59.00K | -1.78M | -1.21M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2.95M | 746.00K | 1.68M | 1.12M | 5.00M |
Cash from Investing | 2.47M | 466.00K | 1.62M | -655.00K | 3.79M |
Total Debt Issued | 0.00 | 0.00 | 0.00 | 71.32M | -- |
Total Debt Repaid | -16.37M | -20.93M | -26.44M | -22.21M | -14.07M |
Issuance of Common Stock | -- | -- | -- | -- | 118.23M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 51.36M | 14.83M | 20.37M | 15.54M | 2.42M |
Cash from Financing | 34.99M | -6.11M | -6.06M | 64.65M | 106.58M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -12.71M | -74.57M | -70.69M | -10.69M | 56.23M |